Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 10 (4) , 837-844
- https://doi.org/10.1016/s0735-1097(87)80278-4
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- Is the renin-angiotensin system really unnecessary in patients with severe chronic heart failure: The price we pay for interfering with evolutionJournal of the American College of Cardiology, 1985
- Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.Circulation, 1985
- Converting-enzyme inhibition for severe chronic heart failure: views from a skepticInternational Journal of Cardiology, 1985
- Prostaglandins in Severe Congestive Heart FailureNew England Journal of Medicine, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981
- LOW-DOSE CAPTOPRIL IN CHRONIC HEART FAILURE: ACUTE HAEMODYNAMIC EFFECTS AND LONG-TERM TREATMENTThe Lancet, 1980
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978
- The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.Journal of Clinical Investigation, 1976